Business Wire (Mon, 16-Dec 1:25 PM ET)
UiPath Reports Third Quarter Fiscal 2025 Financial Results
Business Wire (Thu, 5-Dec 4:10 PM ET)
UiPath to Participate in the Barclays 22nd Annual Global Technology Conference
Business Wire (Wed, 4-Dec 6:27 PM ET)
UiPath Announces Third Quarter Fiscal 2025 Financial Results Conference Call
Business Wire (Thu, 7-Nov 4:10 PM ET)
Deluxe Named UiPath AI25 Award Winner
Business Wire (Thu, 24-Oct 10:00 AM ET)
Omega Healthcare Processes 60 Million Transactions with Enterprise AI and Automation from UiPath
Business Wire (Wed, 23-Oct 5:00 PM ET)
Business Wire (Wed, 23-Oct 2:00 PM ET)
Franaise des Jeux Achieves Significant Efficiency Gains with UiPath's AI-Powered Automation
Business Wire (Wed, 23-Oct 1:00 PM ET)
UiPath Announces 2024 AI25 Award Winners
Business Wire (Wed, 23-Oct 12:00 PM ET)
UiPath Unveils New Vision for the Future: Expanding the Boundaries of AI with Agentic Automation
Business Wire (Tue, 22-Oct 1:00 PM ET)
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Uipath Class A trades on the NYSE stock market under the symbol PATH.
As of January 2, 2025, PATH stock price climbed to $12.93 with 5,167,758 million shares trading.
PATH has a beta of 2.07, meaning it tends to be more sensitive to market movements. PATH has a correlation of 0.20 to the broad based SPY ETF.
PATH has a market cap of $7.11 billion. This is considered a Mid Cap stock.
Last quarter Uipath Class A reported $355 million in Revenue and $.11 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.04.
In the last 3 years, PATH traded as high as $44.13 and as low as $10.37.
The top ETF exchange traded funds that PATH belongs to (by Net Assets): VTI, ARKK, VB, VGT, VXF.
PATH has underperformed the market in the last year with a price return of -47.9% while the SPY ETF gained +24.5%. PATH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +1.0% and -7.0%, respectively, while the SPY returned +2.2% and -2.9%, respectively.
PATH support price is $12.33 and resistance is $13.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PATH shares will trade within this expected range on the day.